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ABSTRACT 
 
 
 
Increased free fatty acid (FFA) flux from adipocytes due to increased lipolysis, 
has a key contribution in the pathophysiology of metabolic disease. There is a 
lack of knowledge of the molecular components which determine the TG storing 
capacity and lipolysis in adipocytes. Studies from our lab and others have 
demonstrated the role of a lipid droplet associated protein, Fat Specific Protein 
27 (FSP27, also called CIDEC), in regulating triglyceride accumulation and 
lipolysis in adipocytes, but its mechanism of action remains elusive. In the 
present study, we used cultured human primary adipocytes to define the role of 
FSP27 in regulating both basal and isoproterenol-stimulated lipolysis. Using a 
combination of RNAi and adenoviral mediated overexpression techniques, we 
have shown that FSP27 regulates ATGL-mediated lipolysis by down-regulating 
gene and protein expression of ATGL. Furthermore, our data shows that FSP27-
mediated triglyceride accumulation is suppressed in the absence of ATGL. Our 
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results support a model whereby FSP27 regulates ATGL-mediated lipolysis to 
accumulate triglycerides in human adipocytes.  
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INTRODUCTION 
The adipose tissue functions as the primary fuel depot in vertebrates, and 
its ability to store energy as triacylglycerols (TAGs) in intracellular lipid droplets 
(LDs) and, on demand, to mobilize these stores via lipolysis, is a highly 
conserved process that is essential for survival (1). Lipid droplets (LDs) are 
intracellular organelles that are composed of a neutral core of triglycerides (TG) 
and cholesterol esters (CE) that are enclosed by a monolayer of phospholipids 
(2,3). Lipolysis is a catabolic branch of the fatty acid (FA) cycle that provides FAs 
in times of metabolic need. FAs are essential substrates for energy production 
and the synthesis of most lipids. Despite their fundamental physiological 
importance, an oversupply of FAs is highly detrimental as increased free fatty 
acids (FFA) causes lipotoxicity which can cause secondary metabolic 
complications such as insulin resistance (4).  
The rate of adipocyte lipolysis in many obese individuals is constitutively 
increased, resulting in elevated levels of circulating FFAs, which may be stored 
as TAG in LDs within skeletal muscle and liver (4). Adipocytes are able to 
secrete FFAs and provide them as systemic energy substrate, whereas non-
adipose cells do not secrete FFAs but utilize them in a cell autonomous manner 
for energy production or lipid synthesis (5). Both local and circulating FFAs are 
important etiologic agents in the development of insulin resistance, 
hyperlipidemia, inflammation, and hepatic steatosis (4). Thus, the balance 
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between TG accumulation and storage, and hydrolysis via lipolysis, called TG 
turnover, is a very important mechanism that needs to be well regulated. 
According to the current model of lipolysis, the hydrolysis of TGs to FAs 
and glycerol requires three consecutive steps that involve three different 
enzymes- adipose tissue glycerol lipase (ATGL; also called desnutrin or 
PNPLA2), Hormone sensitive lipase (HSL), and Monoacylglycerol lipase (MGL). 
ATGL is highly expressed in adipose tissue and is the rate-determining enzyme 
which first initiates lipolysis by specifically removing the first fatty acid from TAG 
to produce DAG substrate, which is then hydrolyzed by HSL to generate an 
additional fatty acid and MAG substrate. MAGs are converted into fatty acid and 
glycerol by MGL in the final step of lipolysis (6). Although HSL is mainly regulated 
by protein kinase A (PKA) phosphorylation, ATGL is coactivated by the protein 
comparative gene identification-58 (CGI-58) and inhibited by the protein G0/G1 
switch gene 2 (1). 
 Under basal conditions in adipocytes, Perilipin A (PLIN1) prevents the 
access of CGI-58 to ATGL, thus decreasing lipolysis (7,8,9). ATGL is mostly 
cytoplasmic under these basal conditions, where a small fraction of ATGL is in 
complex with its inhibitor, G0/G1 switch gene 2, G0S2 (6). Upon β-adrenergic 
stimulation, PKA activation results in phosphorylation of PLIN1 at multiple sites, 
causing the release of CGI-58. CGI-58 then binds and stimulates ATGL (7,10). 
ATGL then translocates from the cytoplasm to the surface of the LDs and 
together with HSL hydrolyse TG. Prolonged β-adrenergic stimulation 
3 
 
subsequently downregulates protein level of G0S2, thereby releasing more ATGL 
for sustained lipolysis.  
The CIDE family proteins CIDEA, CIDEB and FSP27/CIDEC are also LD-
associated proteins and are closely linked to the development of metabolic 
disorders, including obesity, diabetes and liver steatosis (11). FSP27 has been 
shown to be crucial for the fusion of smaller LDs into larger ones (12,13) 
triglyceride (TG) accumulation (14,15,16,17,18). Higher expression of CIDEC 
was found in visceral fat of insulin sensitive compared to insulin resistant obese 
humans (19). Also, a study showed that a mutation in CIDEC results in 
multilocular adipocytes associated with partial lipodystrophy and insulin 
resistance in a human subject (20).  A recent study from our lab has also shown 
that FSP27 plays an important role in regulating LD morphology, whereby it 
interacts with PLIN1 in human adipocytes to promote the formation of large lipid 
droplets (21).  
 
OBJECTIVES OF THE THESIS 
The main objective of this study was to define the role of FSP27 in 
regulating ATGL-mediated lipolysis in human adipocytes. Expressing FSP27 in 
various cell types markedly enhances TG deposition and LD size, whereas 
FSP27 depletion both in vitro and in vivo causes fragmentation of LDs and 
increases TG hydrolysis in adipocytes (12,14,15,17). Another recent study has 
shown that PLIN-1 and FSP27 work in concert to control lipolysis in 3T3-L1 
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adipocytes (1).  
Recent discoveries have highlighted the role of various proteins in the 
lipolytic machinery, however the complexity of lipolysis and its regulation is still 
not completely understood. In particular, the role of FSP27 in regulating lipolysis, 
and its interaction with ATGL has not been studied in human adipocytes. Given 
that FSP27 has been shown to be associated with LDs, we hypothesized that 
FSP27 might be regulating lipolysis to decrease production and circulation of 
FFAs. Thus, peripheral organs (such as skeletal muscle and liver) are protected 
from increased FFA uptake and secondary metabolic complications such as 
insulin resistance. In this study, we used cultured human adipocytes as a model 
system to test our hypothesis.  
Primary pre-adipocytes were harvested from white adipose tissue of 
human subjects. These primary adipocytes were then cultured and differentiated. 
In line with studies done in 3T3-L1 adipocytes by Puri et al (15), we had to first 
establish successful and sustainable knockdown in these cultured human 
adipocytes. Following this, we measured total basal and stimulated (using 
isoproterenol, a β-adrenergic agonist) lipolysis in the FSP27-depleted adipocytes. 
FSP27 depletion resulted in increased basal and stimulated lipolysis in the 
human adipocytes. In contrast, over-expression of FSP27 results in decreased 
basal and stimulated lipolysis, as compared to control cells. These results 
suggest that FSP27 regulates ATGL-mediated lipolysis. To further test this 
hypothesis, we depleted ATGL in the cells and over-expressed FSP27 to see if 
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there is a further reduction of lipolysis in the absence of ATGL. Indeed, we found 
that in the absence of ATGL, there is no further decrease in lipolysis, which 
suggests that FSP27 interacts with ATGL to decrease lipolysis and accumulate 
TGs in human adipocytes.  
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MATERIALS AND METHODS 
 
Cell Culture 
Human pre-adipocytes were procured from the Boston Nutrition Obesity 
Research Center adipocyte core. Cells were seeded at a density of 5,000 
cells/ml/well in a 12-well plate, in Growth Medium which was made using 13.5g 
of α-MEM powder (Gibco) with 10% FBS (Gibco), 100units/ml of penicillin and 
streptomycin (Gibco) and 25mM Sodium Bicarbonate (Fisher Scientific) 
reconstituted in double-distilled water (ddH2O) to 1 liter, pH 7.2-7.3. This growth 
medium was changed every 2 days, until cells reached 90% confluence. In order 
to allow the cells to differentiate, the GM was then replaced by Complete 
Differentiation Medium, which consisted of: 13.5g of Dulbecco’s Modified Eagle’s 
medium powder (DMEM)/F12 (Gibco), 100units/ml of penicillin and streptomycin 
(Gibco), 15mM Hepes (Sigma), 25mM Sodium Bicarbonate (Fisher Scientific), 
33µM Biotin (Sigma), 17µM Pantothenate (Sigma), 0.5mM IBMX (Sigma), 
10mg/L Transferrin (Sigma), 1µM Rosiglitazone (BioMol), 100nM 
Dexamethasone (Sigma), 100nM Human Insulin (Recombinant), 2nM triiodo-l-
thyronine (T3) (Sigma), reconstituted in ddH2O to 1liter, pH 7.4. The day cells 
were first given Complete Differentiation Media is designated as Day 0. The 
media was changed every 2 days until the pre-adipocytes were fully 
differentiated into mature human white adipocytes that were filled with lipid 
droplets. Following differentiation, the cells were maintained in Maintenance 
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medium until fully differentiated with the media being changed every 2 days. 
Maintenance medium was made of the similar constituents as Complete 
Differentiation media, except without Rosiglitazone, IBMX, T3 and Transferrin. 
Additionally, the concentrations of Human Insulin and Dexamethasone used was 
10nm each. 
 
siRNA Treatment and Adenoviral Transduction 
The following siRNA constructs were used for experiments: siScr (from Qiagen)- 
All Stars Negative Control; human siFSP27 (from Dharmacon)- AAC-UGU-ACA-
GAC-AGA-AGA-GUA-UU; siATGL (from Invitrogen)- ACC-UGC-CAC-UCU-AUG-
AGC-UUA-AGA-A. On Day 9 following differentiation, cultured adipocytes were 
transfected with 40nm siRNA, 5µl/well PLUS reagent and 3µl/well Lipofectamine 
reagent all from Invitrogen, in a total volume of 350µl/well (100µl siRNA mixture, 
250µl MM). 24hrs post-transfection, 500µl Maintenance Media was added to 
cells.  The media was then changed 24hrs later with 1ml of Maintenance Media. 
Cells were further incubated for 3 days (Day 14) before being harvested for 
analysis. FSP27-HA tagged adenoviruses were generated at the Adenoviral 
Vector Core Facility at Tufts Medical Center. ATGL-CFP and FSP-CFP 
adenovirus was a kind gift from Dr Carol Sztalryd and Dr Dawie Gong from the 
University of Maryland. The adenovirus was added to adipocytes on either Day 9 
(if experiment was solely studying effects of over-expression) or on Day 14 (for 
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re-expression analysis) of differentiation at m.o.i of 100. Cells were then 
harvested 48hrs post-infection for analysis. 
 
RNA Isolation and qPCR 
Total RNA was isolated from human adipocytes from each well (12-well plate) 
with 1ml TRIzol (Invitrogen). Total RNA isolation was performed as described in 
the manufacturer’s protocol and RNA concentrations were measured on a 
NanodropTM nd-1000 spectrophotometer (Thermo-Scientific). For quantitative 
PCR (mRNA analysis), 1 µg of RNA was reverse transcribed with Transcriptor 
First Strand cDNA Synthesis Kit (Roche). The cDNA was diluted 1:10 and 1µl 
was used for each reaction (per well, 384-well plate) in triplicates. Primers 
(TaqMan) were used with Roche LightCycler 480 Probes Master kit (Roche 
Applied Science) at 0.25µl, with 2.5µl Master stock and 1.25µl ddH2O per 
reaction. Thermal cycling conditions were: 10 min at 95°C for activation, 45 
cycles of 10 seconds at 95°C, 30 seconds at 60°C and 1 second at 72°C for 
reactions, and 5 min at 37°C for cooling down. Comparative-ΔCt method was 
used to calculate relative changes in mRNA abundance. 
 
Protein Quantification and Analysis 
Cells were lysed in Cell Lysis Buffer (Cell Signaling) with 5% SDS, protease 
inhibitor cocktail (Roche) and phosphatase inhibitor cocktail (Roche). Protein 
lysates were then briefly sonicated, incubated in a 37°C water bath for 30 
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minutes, and then centrifuged at 10,000rpm for 10 minutes. The clear middle 
phase of the solution was then collected as the protein sample. Protein 
quantification was performed using the Pierce BSA Protein Assay Kit (Thermo 
Scientific). Immunoblots (Western Blot) were performed using 10% and 15% 
Tris-HCl gels (Bio-Rad), run at 100 volts for 90 minutes, and transferred to PVDF 
membranes (Bio-Rad), run at 60 volts, for 120 minutes. Primary antibodies used 
were all diluted in 2% BSA in TBS-T. Antibodies used were: mouse anti-β-tubulin 
(Invitrogen, 1:5000 dilution), rabbit anti-FSP27 (1:4000 dilution), and rabbit IgG 
anti-ATGL (1:5000 dilution). Secondary antibodies were purchased from Santa 
Cruz Biotechnology (1:10000 dilution).  
 
Triglyceride Accumulation and Lipolysis  
For analysis of total cellular glycerol release (measure of lipolysis), cells were 
incubated in Krebs-Ringer buffer (KRB) with 4% BSA for 2.5 hours. At the end of 
the 2.5 hours, the KRB was collected and analyzed for glycerol release (basal 
lipolysis). For stimulated lipolysis, after 1.5 hours of incubation with KRB, cells 
were treated with 1µm Isoproterenol (Sigma), a β-adrenergic agonist, for 1 hour. 
For total cellular triglyceride (TG) content analysis, after collection of the KRB 
buffer supernatant, cells were harvested with 1x SDS Triglyceride lysis buffer 
(0.1% SDS, 1mM EDTA and 100mM Tris-HCl, adjusted to pH 7.4). Total cellular 
triglyceride content and basal/stimulated lipolysis assays were measured by 
using the Serum Triglyceride Determination Kit from Sigma-Aldrich according to 
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the manufacturer’s instructions. Concentrations were determined by 
normalization to the standard curves; TG was further normalized to total protein 
content, and lipolysis was normalized to TG content and molecular weight of 
glycerol (92.09 g/mol). 
 
Statistics 
Quantitative data are presented as mean ± standard error. Statistical significance 
was calculated using paired student’s t-test. A p-value of less than 0.05 was 
considered statistically significant. 
 
RESULTS 
Knockdown of FSP27 using siRNA is stable for at least up to 10 days after 
siRNA transfection.       
The main purpose of this preliminary experiment was to establish that the siRNA 
construct for FSP27 works and that we were able to achieve significant and 
sustainable knockdown of FSP27 in human adipocytes. Human white adipocytes 
were differentiated as described in methods. On day 9 of differentiation, the cells 
were treated with 40nm siScr (control) or siFSP27 for 5 or 10 days. Following 
these time points, the cells were harvested and the protein expression levels of 
FSP27 and endogenous control, β-tubulin, were measured by Western Blotting. 
As shown in Fig. 1, we were able to achieve greater than 90% knockdown of 
FSP27 in human adipocytes after 5 days of transfection. This knockdown was 
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sustainable even after 10 days post-transfection, which shows about 90% 
knockdown in FSP27 protein expression compared to the negative control, siScr. 
We thus established that 40nm of siRNA was sufficient to induce knockdown of 
FSP27 in cultured human adipocytes in 5 days. 
 
Fig. 1 Protein expression of FSP27 and β-tubulin in control siSCR and siFSP27 
treated cells at 5 and 10 days post-siRNA treatment. Primary cultures of mature 
white adipocytes were grown, differentiated and treated with siRNA as described in 
methods. siSCR (scrambled) was used as a control. Protein lysates were loaded at 
15ug/lane and probed with antibodies against FSP27 and β-tubulin. Image is 
representative of at least three independent experiments. 
 
FSP27 depletion increases both basal and stimulated lipolysis in human 
adipocytes. 
Studies from our lab and others have shown the role of FSP27 in lipid 
droplet dynamics and lipolysis in 3T3-L1 adipocytes (1,15). In order to investigate 
if FSP27 plays a role in both basal and stimulated lipolysis in human adipocytes, 
we used siRNA-mediated approach to knockdown FSP27 in cultured human 
adipocytes, as established from Fig. 1. In order to investigate the role of FSP27 
depletion on basal and stimulated lipolysis, we measured free glycerol release 
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(as a measure of lipolysis) in cells at basal level (no treatment) and upon 
stimulation with a β-adrenergic agonist, isoproterenol (1µm, 1 hour). As shown in 
Fig. 2, FSP27 depletion caused a 20% increase in basal lipolysis and a 40% 
increase in stimulated lipolysis. These results suggest that FSP27 plays a role in 
both basal and stimulated lipolysis in human adipocytes. 
 
Fig. 2 Basal and stimulated lipolysis in siSCR and siFSP27 treated cells. Primary 
adipocytes were cultured, differentiated and treated with siRNA as described in 
methods. 5 days post-siRNA treatment, cells were treated with KRB albumin buffer 
(basal) or with KRB albumin buffer with β-agonist isoproterenol (stimulated), and 
harvested for total glycerol release as described in methods. The data show an average 
of three independent experiments. Values are means ± standard error; ∗p < 0.05 (paired 
t-test). 
 
FSP27 decreases ATGL-mediated lipolysis in human adipocytes. 
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ATGL is a hydrolase that controls the rate-determining step in lipolysis and 
is critical for regulating lipolysis in human adipocytes. Based on our results in Fig. 
2 showing that depletion of FSP27 promotes both basal and stimulated lipolysis, 
we hypothesized that FSP27 might regulate ATGL-mediated lipolysis. To 
investigate the role of FSP27 in regulating ATGL activity we first performed co-
immunoprecipitation to analyze if FSP27 interacts with ATGL. This experiment 
was performed by Dr Grahn in our lab, and she found that indeed, FSP27 
interacts with ATGL in vitro (manuscript in preparation). Cultured adipocytes 
were infected with adenoviral preparations of FSP27-HA, ATGL-CFP, or both, as 
described in the methods.  
As expected in Fig. 3, over-expression of FSP27 caused a 3.5 fold 
decrease in basal lipolysis (p<0.05) and a 30% decrease in stimulated lipolysis, 
as compared to the control. In contrast, over-expression of ATGL caused a 60% 
increase in basal lipolysis, and an 82% increase in stimulated lipolysis when 
compared to control. However, when expressed in conjunction with FSP27-HA, 
ATGL-mediated increase in basal and stimulated lipolysis was suppressed by 
52% and 70% respectively, when compared to ATGL on its own. It is interesting 
and important to note that we did not see as much as an increase in stimulated 
lipolysis in the control cells as compared to the huge induction we saw in Fig. 2. 
This is because there is usually some residual side-effects of treatment with 
adenovirus and the control cells were treated with adenoviral preparation of 
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eGFP. However, on a whole, these results indicate that FSP27 overrides ATGL-
catalyzed lipolysis in human adipocytes. 
Fig. 3 Basal and stimulated lipolysis in FSP27-HA and ATGL-CFP treated cells. 
Primary adipocytes were cultured, differentiated and treated with adenoviral preparations 
of FSP27-HA and ATGL-CFP as described in methods. 48hrs post infection, cells were 
treated with KRB albumin buffer (basal) or with KRB albumin buffer with β-agonist 
isoproterenol (stimulated), and harvested for total glycerol release as described in 
methods. Light grey columns represents basal lipolysis, and dark grey columns 
represent stimulated lipolysis. The data show an average of three independent 
experiments. Values are means ± standard error; ∗p < 0.05 (paired t-test). 
 
FSP27 regulates ATGL gene and protein expression levels. 
Given that FSP27 depletion or expression increases or decreases ATGL-
mediated basal and stimulated lipolysis respectively, we next examined if FSP27 
has any role in regulating ATGL expression. Cultured adipocytes were treated 
with siRNA against FSP27. Scrambled siRNA was used as a control. 5 days 
post-transfection, the cells were harvested and RNA was extracted and relative 
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mRNA expression of FSP27, ATGL and PLIN1 was measured in these cells. 
FSP27 depletion has previously been shown to increase PLIN1 expression (22). 
PLIN1 is an adipocyte-specific lipid-droplet associated protein that has been 
shown to interact with FSP27 to increase FSP27-mediated lipid exchange, lipid 
transfer and lipid droplet growth (11,21). Functional cooperation between PLIN1 
and FSP27 is required for efficient lipid droplet growth in adipocytes, as depletion 
of either protein impairs lipid droplet growth (11).  
 
Fig. 4 FSP27 depletion increases ATGL and PLIN1 gene expression in human 
adipocytes. Primary adipocytes were cultured, differentiated and treated with siRNA as 
described in methods. 5 days post-transfection, RNA was extracted from the cells and 
mRNA levels were measured by quantitative-PCR. Columns represent relative fold-
change in mRNA levels. Light grey columns are cells treated with control siSCR and 
dark grey columns are cells treated with siFSP27. The data show an average of three 
independent experiments. Values are means ± standard error; ∗p < 0.05 (paired t-test). 
 
 As shown in Fig. 4, treatment with siFSP27 resulted in 70% knockdown of 
FSP27. This decrease in FSP27 mRNA level resulted in a 2.8 fold increase in 
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ATGL and 3.8 fold increase in PLIN1 mRNA levels. Next, we examined the effect 
of FSP27 depletion on ATGL protein expression. As shown in Fig. 5, 80% 
knockdown of FSP27 resulted in 84% increase in ATGL protein expression. This 
data is consistent with the decrease in the level of genes. 
 
Fig. 5 FSP27 depletion increases ATGL protein expression in human adipocytes. 
Primary cultures of mature white adipocytes were grown, differentiated and treated with 
siRNA as described in methods. siScr (scrambled) was used as a control. Protein 
lysates were loaded at 15ug/lane and probed with antibodies against FSP27, ATGL or β-
tubulin. Image is representative of at least three independent experiments. 
 
 Since FSP27 depletion increases both gene and protein expression of 
ATGL, this suggests that FSP27 plays a role in regulating its transcription. 
Therefore, we next wanted to examine if over-expressing FSP27 decreases 
ATGL gene and protein expression to reduce its hydrolase activity. Cultured 
adipocytes were treated with either adenoviral preparations of FSP27-CFP, 
FSP27-HA or siATGL and were then harvested and the RNA was extracted as 
described in methods. Relative mRNA levels of FSP27, PLIN1 and ATGL were 
then measured using quantitative PCR. As shown in Fig. 6, infecting cells with 
FSP27-CFP adenovirus caused 50% increase in mRNA level of FSP27. Also, 
FSP27-HA adenovirus increased FSP27 expression by 5-fold (p<0.05) in human 
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adipocytes. This correlated with a 90% and 63% increase, respectively, in FSP27 
protein levels (Fig.7). However, it is important to note that our qPCR primers 
detect endogenous FSP27, so somehow infection with the HA-adenovirus 
increases endogenous FSP27 gene expression.
 
Fig. 6 FSP27 over-expression decreases ATGL gene expression in human 
adipocytes. Cultured adipocytes were treated with adenoviral preparations of FSP-CFP, 
FSP-HA or siATGL. RNA was extracted from the cells and mRNA levels were measured 
by quantitative PCR. Columns represent relative fold-change in mRNA levels as 
compared to endogenous control, GAPDH. The data show an average of three 
independent experiments. Values are means ± standard error; ∗p < 0.05 (paired t-test). 
 
While treatment with siRNA against ATGL resulted in a 70% decrease in 
ATGL mRNA levels, there seemed to be only a slight increase (30%) in CIDEC 
mRNA levels. However, cells treated with both FSP27-CFP and FSP27-HA 
resulted in 63% and 66% decrease in ATGL mRNA levels respectively. This 
correlates with a 30% and 70% decrease in ATGL protein levels respectively 
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(Fig. 7). While FSP27 depletion caused an increase in PLIN1 mRNA levels, over-
expression of FSP27 resulted in a mild decrease in PLIN1 mRNA levels (about 
30%) and a 47% decrease when treated with siATGL. Thus, in combination with 
the results from Fig. 4 and 5, we can surmise that changes in FSP27 expression 
modulates ATGL gene and protein expression levels to regulate its hydrolase 
activity. 
 
 
Fig. 7 FSP27 over-expression decreases ATGL protein expression in human 
adipocytes. Cultured adipocytes were treated with adenoviral preparations of FSP27-
CFP or FSP27-HA for 48hrs. Cells were then harvested and the protein lysates were 
loaded at 15ug/lane and probed with antibodies against FSP27, ATGL and β-tubulin. 
Image is representative of experiment performed in triplicates. 
 
FSP27-mediated TG accumulation is ATGL dependent. 
 Accumulating evidence supports the role of FSP27 in TG accumulation 
(14,15). The results thus far have established that FSP27 interacts with ATGL 
and negatively regulates its activity. As shown in Fig. 8a, in the absence of ATGL 
(knockdown via siRNA), basal lipolysis is suppressed by 91%. Additionally, as 
shown before in Fig. 3, exogenous expression of FSP27-HA suppresses lipolysis 
by 83%. There is no further decrease in lipolysis when cells were depleted of 
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ATGL and treated with exogenous FSP27. This shows that indeed FSP27 
interacts with ATGL to regulate its hydrolytic activity. 
 
Fig. 8a FSP27 does not further decrease lipolysis in the absence of ATGL. 
Biochemical quantification of total basal lipolysis in Scrambled siRNA (siSCR) and ATGL 
siRNA (siATGL) treated human adipocytes. 5 days post-transfection, cells were treated 
with FSP27-HA adenovirus for 48hrs as described in methods. For lipolysis, glycerol 
released in 2.5hrs was measured and normalized to total celluar triglyceride. The data 
show an average of three independent experiments. Values are means ± standard error; 
∗p < 0.05 (paired t-test). 
 
We next hypothesized that FSP27 mediates TG accumulation by 
suppressing the activity of ATGL. To address this, ATGL was first depleted from 
cultured human adipocytes using siRNA. FSP27 was then delivered to the 
adipocytes using adenovirus. The cells were infected with FSP27-HA adenovirus 
for 48hrs. As shown in Fig. 8b, cells expressing FSP27-HA accumulated 
significantly higher amount of TG compared to Scrambled siRNA control cells (3-
fold increase). However, knockdown of ATGL attenuated the ability of exogenous 
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FSP27 to accumulate TG, to a level similar to that in cells depleted of ATGL (Fig. 
8, second column, siATGL), which is about a 90% increase in TG. This data 
strongly suggests that FSP27-mediates TG accumulation by inhibiting ATGL-
mediated lipolysis (and thus its hydrolase activity), highlighting the role of ATGL-
mediated lipolysis in FSP27-mediated TG accumulation.
 
Fig. 8b FSP27-mediated TG accumulation is ATGL dependent. Biochemical 
quantification of total triglyceride in human adipocytes treated with siSCR control and 
siATGL as described in methods. 5-days post siRNA transfection, cells were treated 
FSP27-HA adenovirus for 48hrs. Total triglyceride was measured and normalized to total 
protein. The data show an average of three independent experiments. Values are 
means ± standard error, ∗p < 0.05 (paired t-test). 
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DISCUSSION 
Impaired TG storage and chronic exposure to FFA release from 
adipocytes via increased lipolysis leads to whole body insulin resistance. This 
study demonstrates the interaction of a lipid droplet protein, FSP27 with a lipase, 
ATGL, to regulate lipolysis and improve the lipid storage capacity of adipocytes. 
The results show that FSP27 interacts with ATGL and reduces its lipolytic 
capacity. Interestingly, FSP27-mediated TG accumulation was suppressed in the 
absence of ATGL indicating an important contribution of ATGL-mediated lipolysis 
in the TG storage capacity of adipocytes. FSP27 depletion increased both basal 
and isoproterenol stimulated lipolysis in human adipocytes. Importantly, another 
study in our lab has found that overexpression of FSP27 protected human 
adipocytes from FFA-mediated insulin resistance (data not shown). 
Previous studies showed that depletion of FSP27 increases basal and 
stimulated lipolysis (1,15) in 3T3-L1 adipocytes. A recent study proposed that 
FSP27 might limit the LD presence of ATGL due to FSP27’s function in 
regulating LD morphology (1). The absence of FSP27 resulted in 
multilocularization of LDs, thus it was proposed that increasing total surface area 
of the LDs due to fragmentation increase the access of ATGL to the LD surface, 
leading to increased lipolysis. As a matter of fact, a previous study (15) showed 
that FSP27 depletion resulted in fragmentation of LDs in adipocytes. 
Interestingly, our recent study (21) showed that overexpression of FSP27 and 
PLIN1 leads to the formation of enlarged LDs without affecting the lipolytic rates 
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in cultured human adipocytes. In this study there was no effect of lipid droplet 
morphology on lipolysis in human adipocytes, suggesting that besides regulating 
LD morphology there is an additional level of regulation of lipolysis by FSP27.  
An important aspect of the present study is that our results are relevant to 
human physiology, as all experiments were performed using cultured human 
adipocytes. Our studies in laboratory show that FSP27 interacts with ATGL 
(Grahn et al., in preparation).  We found that FSP27 depletion causes an 
increase in both basal and stimulated lipolysis in human adipocytes (Fig. 2). In 
order to study the gain of function, we overexpressed ATGL and/or FSP27 in 
COS7 cells and mature human adipocytes. Interestingly, FSP27 expression 
suppressed ATGL-mediated lipoysis in both the model systems, indicating a 
direct role of FSP27 in regulating ATGL-mediated lipolsis.  
This study did not address whether FSP27 interacts with ATGL directly or 
indirectly and whether it interacts with ATGL on the lipid droplet surface. Since 
FSP27 and ATGL are present in other compartments like the endoplasmic 
reticulum in adipocytes, it is possible that FSP27 interacts with ATGL in these 
compartments as well. Nonetheless, our study clearly shows the role of FSP27 in 
the regulation of ATGL-mediated lipolysis in human adipocytes. 
The molecular mechanism whereby FSP27 regulates ATGL-mediated 
lipolysis is unknown. Adipocyte lipolysis is initiated when catecholamines bind to 
β-adrenergic receptors on the surface of a cell (23). Through the action of a 
stimulatory G-protein, adenylate cyclase is activated, leading to increased 
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intracellular cAMP and activation of cAMP-dependent PKA. PKA phosphorylates 
both PLIN1 and HSL (23,24,25,26). It is the PKA-dependent phosphorylation of 
PLIN1 that causes the release of CGI-58, leading to the initiation of lipolysis by 
activating ATGL (7,25,27). In the present model of lipolysis, PLIN1 binds CGI-58 
in the basal state, limiting its access to ATGL, but it is not clear what restrains 
ATGL from binding CGI-58. Complementary to the current model, we propose a 
potential model in which FSP27 interacts with ATGL at the surface of lipid droplet 
and limits its access to CGI-58. 
Our recent study showed that FSP27 interacts with PLIN1 at the lipid 
droplet surface (21). We propose here that PLIN1 being a scaffolding protein, 
interacts with FSP27 and helps it to stay and interact with ATGL at the droplet 
surface, but that only ATGL directly interacts with FSP27 (but not with PLIN1). In 
contrast, PLIN1 directly interacts with CGI-58 (28,29). However, what is not 
known is if the domain of ATGL that FSP27 binds to is the “active” site that is 
bound by CGI-58 to activate lipolysis. Our model is consistent with our data that 
FSP27 depletion increases lipolysis in human adipocytes under both basal and 
stimulated conditions, which is probably due to the release of FSP27-interacting 
with ATGL, which now gains an access to CGI-58. We cannot ignore the 
possibility that FSP27 regulation of LD morphology can add to the process of 
ATGL-regulated liplysis. But this hypothesis remains to be tested. 
 
24 
 
Our study also tested the possibility of the regulation of ATGL expression 
by FSP27. Surprisingly, knock down of FSP27 increased the expression of ATGL 
in human adipocytes. In contrast, the overexpression of FSP27 decreased ATGL 
expression. These studies clearly show that besides regulating the activity of 
ATGL, FSP27 could also regulate the transcription and translation of ATGL. 
Future studies are needed to describe the molecular mechanism of FSP27 
regulation of ATGL expression. Overall, our studies show that FSP27 regulates 
the lipolysis in human adipocytes by regulating the activity as well as expression 
of ATGL.  
FSP27 has previously been shown to play a role in TG accumulation in 
adipocytes (12,15,30). Precisely how FSP27 regulates TG accumulation is 
unclear. Based upon our results showing FSP27-ATGL interaction and regulation 
of ATGL-mediated liplysis by FSP27, we hypothesize that FSP27-mediated TG 
accumulation is due to its role in lipolysis regulation, i.e. FSP27 reduces lipolysis 
of stored TGs to increase their content. Indeed, our results showed that FSP27-
mediated TG accumulation in human adipocytes was impaired upon ATGL 
depletion. Furthermore, when ATGL was depleted from cells, there was a 
significant decrease in basal lipolysis, however, when FSP27 was co-expressed 
in these ATGL-depleted cells, there was no further decrease in lipolysis, which 
suggests that FSP27-mediated regulation of lipolysis and TG accumulation was 
specifically ATGL-dependent.  
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